文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

重度ARDS患者接受体外膜氧合期间的俯卧位通气:PRONECMO随机临床试验

Prone Positioning During Extracorporeal Membrane Oxygenation in Patients With Severe ARDS: The PRONECMO Randomized Clinical Trial.
PubMed 文献 · JAMA · 2023-01-01
一句话结论在VV-ECMO支持的重度ARDS患者中,与仰卧位相比,俯卧位通气未显著缩短成功脱离ECMO的时间(44% vs 44%,P=0.64)。

PRONECMO是一项在法国14个ICU开展的随机临床试验,纳入170例接受VV-ECMO不足48小时的重度ARDS患者(94%为COVID-19相关ARDS,96%在ECMO前已俯卧位),1:1随机分为俯卧位组(至少4次、每次16小时,n=86)和仰卧位组(n=84)。主要终点60天内成功脱离ECMO的比例两组均为44%(38/86 vs 37/84;风险差0.1%[95%CI -14.9%至15.2%];亚分布风险比1.11[95%CI 0.71-1.75];P=0.64)。90天内ECMO持续时间(28 vs 32天;差值-4.9[95%CI -11.2至1.5]天;P=0.13)、ICU住院时间及90天死亡率(51% vs 48%;风险差2.4%[95%CI -13.9%至18.6%];P=0.62)均无显著差异。俯卧位操作期间未报告严重不良事件。

要点

  • 在VV-ECMO支持的重度ARDS患者中,俯卧位组与仰卧位组60天内成功脱离ECMO比例均为44%(38/86 vs 37/84;风险差0.1%[95%CI -14.9%至15.2%];P=0.64)。
  • 两组90天内ECMO持续时间分别为28天与32天(差值-4.9[95%CI -11.2至1.5]天;P=0.13),无显著差异。
  • 90天死亡率俯卧位组51% vs 仰卧位组48%(风险差2.4%[95%CI -13.9%至18.6%];P=0.62),无显著差异。
  • 俯卧位方案为至少4次、每次16小时;俯卧位操作期间未报告严重不良事件。
  • 研究人群以COVID-19相关ARDS为主(159/170,94%),且96%(164/170)在ECMO启动前已接受俯卧位。

适用人群与场景

  • 在法国14个ICU接受VV-ECMO不足48小时的重度ARDS患者,随机化时中位年龄51岁(IQR 43-59),女性60例(35%)。
  • 中位呼吸系统顺应性15.0 mL/cm H2O(IQR 10.7-20.6);159例(94%)为COVID-19相关ARDS。
  • 164例(96%)在ECMO启动前已处于俯卧位。

处置流程与药物剂量

  • 俯卧位组接受至少4次俯卧位,每次16小时;仰卧位组保持仰卧位。
  • 研究期间俯卧位操作未报告严重不良事件。

研究设计与关键结果

  • 研究类型:随机临床试验;170例患者随机1:1分为俯卧位组(n=86)与仰卧位组(n=84);法国14个ICU;入组时间2021年3月3日至2021年12月7日。
  • 主要终点:60天内成功脱离ECMO,俯卧位组38/86(44%)vs 仰卧位组37/84(44%);风险差0.1%(95%CI -14.9%至15.2%);亚分布风险比1.11(95%CI 0.71-1.75);P=0.64。
  • 90天内ECMO持续时间:俯卧位组28天 vs 仰卧位组32天;差值-4.9(95%CI -11.2至1.5)天;P=0.13。
  • 90天死亡率:俯卧位组51% vs 仰卧位组48%;风险差2.4%(95%CI -13.9%至18.6%);P=0.62。
  • ICU住院时间无显著差异。
  • 俯卧位操作期间未报告严重不良事件。

证据类型、等级与局限

  • 证据类型:随机临床试验(RCT)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在VV-ECMO支持的重度ARDS患者中,俯卧位通气与仰卧位相比未显著缩短成功脱离ECMO的时间,作者结论为俯卧位未显著减少脱离ECMO时间。

指南或共识出处

  • PRONECMO随机临床试验(ClinicalTrials.gov Identifier: NCT04607551)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Prone positioning may improve outcomes in patients with severe acute respiratory distress syndrome (ARDS), but it is unknown whether prone positioning improves clinical outcomes among patients with ARDS who are undergoing venovenous extracorporeal membrane oxygenation (VV-ECMO) compared with supine positioning.

OBJECTIVE: To test whether prone positioning vs supine positioning decreases the time to successful ECMO weaning in patients with severe ARDS supported by VV-ECMO.

DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial of patients with severe ARDS undergoing VV-ECMO for less than 48 hours at 14 intensive care units (ICUs) in France between March 3, 2021, and December 7, 2021.

INTERVENTIONS: Patients were randomized 1:1 to prone positioning (at least 4 sessions of 16 hours) (n = 86) or to supine positioning (n = 84).

MAIN OUTCOMES AND MEASURES: The primary outcome was time to successful ECMO weaning within 60 days following randomization. Secondary outcomes included ECMO and mechanical ventilation-free days, ICU and hospital length of stay, skin pressure injury, serious adverse events, and all-cause mortality at 90-day follow-up.

RESULTS: Among 170 randomized patients (median age, 51 [IQR, 43-59] years; n = 60 women [35%]), median respiratory system compliance was 15.0 (IQR, 10.7-20.6) mL/cm H2O; 159 patients (94%) had COVID-19-related ARDS; and 164 (96%) were in prone position before ECMO initiation. Within 60 days of enrollment, 38 of 86 patients (44%) had successful ECMO weaning in the prone ECMO group compared with 37 of 84 (44%) in the supine ECMO group (risk difference, 0.1% [95% CI, -14.9% to 15.2%]; subdistribution hazard ratio, 1.11 [95% CI, 0.71-1.75]; P = .64). Within 90 days, no significant difference was observed in ECMO duration (28 vs 32 days; difference, -4.9 [95% CI, -11.2 to 1.5] days; P = .13), ICU length of stay, or 90-day mortality (51% vs 48%; risk difference, 2.4% [95% CI, -13.9% to 18.6%]; P = .62). No serious adverse events were reported during the prone position procedure.

CONCLUSIONS AND RELEVANCE: Among patients with severe ARDS supported by VV-ECMO, prone positioning compared with supine positioning did not significantly reduce time to successful weaning of ECMO.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04607551.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Schmidt M, Hajage D, Lebreton G, et al. Prone Positioning During Extracorporeal Membrane Oxygenation in Patients With Severe ARDS: The PRONECMO Randomized Clinical Trial. JAMA. 2023. PMID: 38038395. doi:10.1001/jama.2023.24491

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。